CLINICAL ROLE -
Carving Out a Niche in the Treatment of Tardive Dyskinesia
The FDA recently approved Ingrezza (valbenazine) for the treatment of adults with tardive dyskinesia.
Read More
FDA Approves Opioid Dependence Treatment
Buprenorphine and naloxone buccal film (Bunavail) approved for a revised indication to include use for the initiation of buprenorphine treatment for opioid dependence.
FDA Approves Bunavail for Induction of Opioid Dependence Treatment
Officials with the FDA have approved the supplemental new drug application (sNDA) for BioDelivery Sciences International's buprenorphine and naloxone buccal film (Bunavail).
NCPA Provides Recommendations for Strengthening Medicare Part D
Rotavirus Vaccine: Living Up to Expectation
Researchers from the CDC in Atlanta, Georgia, recently published a study that looked at rotavirus vaccinations’ global impact.
Manufacturer Channel Strategy for Specialty Drugs
Exclusive, limited, and open networks each have pros and cons that must be weighed heavily.
Diet Lacking 2 Amino Acids Slows Tumor Growth, Prolongs Survival
Cutting supply of essential nutrients restrains tumors.
Pharmacists Find Diabetic Neuropathy in Rural Areas
Diabetes is quickly becoming a rural problem in the United States.
Diabetes and Rural Areas: Pharmacists Identify Neuropathy
Patients in rural areas who have diabetes often have lower access to care and are more likely to be uninsured, hospitalized, or poor.
Does Antibiotic Exposure Lead to Miscarriage Risk?
New research published in the Canadian Medical Association Journal suggests that some commonly prescribed antibiotics may be linked to higher risk of miscarriage in early pregnancy.
Cannabis Shows Seizure Relief in Hard-to-Treat Epilepsy
Liquid cannabidiol reduced seizures up to 50% in some patients with Lennox-Gastaut syndrome.
Real-World Data Shows Tecfidera, Tysabri Improve Outcomes in MS Patients
New analyses show the benefits of early treatment with Tefidera (dimethyl fumarate) and Tysabri (natalizumab).
WHO Report Slashes Number of Worldwide Hepatitis C Cases
Estimates of patients with HCV dropped from 130 million to 71 million.
Inflammatory Bowel Disease Driven by Cytokine
Interleukin cytokine involved with inflammatory bowel disease pathology.
Novel Blood Test May Provide More Personalized Treatments for Lung Cancer Patients
Blood test quickly and accurately identifies genetic mutations linked to non-small cell lung cancer.
Scientists Discover Why Pancreatic Cancer is Aggressive
Key factor helps drive metastases in aggressive cancers.
Foodborne Illnesses Remain Significant Health Issue
Campylobacter and Salmonella caused the most reported bacterial foodborne illnesses in 2016.
Newly Approved Osteoporosis Drug Carries Cancer Risk
Tymlos, an injection that treats postmenopausal women with osteoporosis, may incrase the risk of osteosarcoma.
Mechanisms of Rheumatoid Arthritis-Associated Interstitial Lung Disease
Interstitial lung disease, a common complication of rheumatoid arthritis, often leads to deteriorating health.
False Claims Act and Pharmacy Practice: Pharmacists Beware!
It is alarming how much health care fraud within the pharmacy is being prosecuted by the Office of Inspector General.
How Will CMS Changes to Medicare Part D Affect Retail Pharmacy in 2018?
See what changes are coming to retail pharmacy for Medicare Part D in 2018.
Hematology Oncology Pharmacy Association to Host Upcoming Policy Summit
The Hematology Oncology Pharmacy Association (HOPA) is hosting the HOPA Policy Summit on Drug Waste in the Treatment of Cancer with health care professionals and industry members.
Generic Hypertension Drug Gains FDA Approval
Generic version of olmesartan medoxomil and hydrochlorothiazide tablets treat hypertension to lower blood pressure.
Academy of Managed Care Pharmacy Releases Multi-Stakeholder Findings to Drive Value and Outcomes in Oncology
FDA Approves Generic Hypertension Treatment
The FDA has approved Aurobindo Pharma’s generic version of olmesartan medoxomil and hydrochlorothiazide tablets in 20 mg/12.5 mg, 40 mg/12.5 mg, and 40 mg/25 mg doses.
Talk to Me! The Importance of Face-to-Face Communication at Shift Change
In 2016, retail pharmacists in the United States dispensed more than 4.4 billion prescriptions from 58,000 retail locations. What happens at change of shift in these pharmacies, and how can we improve?
ACCP White Paper: Guidance on Natural Products
ACCP has updated its white paper on natural products, and published it in the January issue of the journal Pharmacotherapy.
Challenges for Value-Based Contracting in Specialty Pharmacy
The transition to value-based reimbursement is likely to shape the future of health care.